Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001144204-12-027203
Filing Date
2012-05-09
Accepted
2012-05-09 16:35:51
Documents
7
Period of Report
2012-06-17

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT v312191_pre14a.htm PRE 14A 507586
2 GRAPHIC logo.jpg GRAPHIC 13325
3 GRAPHIC sig1.jpg GRAPHIC 4223
4 GRAPHIC sig2.jpg GRAPHIC 4133
5 GRAPHIC sig3.jpg GRAPHIC 4115
6 GRAPHIC proxy01.jpg GRAPHIC 139535
7 GRAPHIC proxy02.jpg GRAPHIC 426747
  Complete submission text file 0001144204-12-027203.txt   1325387
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-33357 | Film No.: 12826240
SIC: 2836 Biological Products, (No Diagnostic Substances)